A six-month follow-up schedule to run with your nephrologist
Quick answer
The main endpoints are the eGFR trend and the urine albumin-to-creatinine ratio, comparing a pre-treatment baseline with values at one, three and six months. A meaningful result is a flatter decline or a falling UACR — not how you feel, and not one isolated reading.
The baseline matters most: get at least two pre-treatment values about three months apart so the existing slope is visible. With a single baseline point you cannot separate treatment effect from natural fluctuation.
UACR responds faster than eGFR and is often the short-term marker, but collection technique matters: avoid samples taken during fever, hard exercise or menstruation, which inflate the value.
Use the same laboratory where possible: creatinine assays differ slightly between labs, and comparing across them can make a patient believe they improved or deteriorated when only the method changed.
Dehydration, high-protein meals, some medications and infections all shift creatinine temporarily.
It helps when unusual muscle mass makes creatinine hard to interpret; let your physician decide.
Good for quality of life, but not a substitute for labs — diuretic changes or less salt can explain it.
Keep dated files with the lab name and the medications in use at the time; it sharpens trend interpretation.
See a doctor promptly to find the cause — dehydration, infection or an adverse effect — rather than waiting it out.
5 points • reviewed 2026-09-02
Reviewed and last updated: 2026-09-02
5 sources • every claim is traceable
https://www.ehlbio.co.kr
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories